Market Tracker

09/02 6:05pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

35.44
Data as of Sep 02
 -0.75 / -2.07%
Today’s Change
20.02
Today|||52-Week Range
42.50
+68.92%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close36.19
Today’s open36.15
Day’s range35.22 - 36.49
Volume813,658
Average volume (3 months)846,899
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-20.65%
Earnings growth (next 5 years)+15.22%
Revenue growth (last year)+26.92%
P/E ratio15.8
Price/Sales3.79
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
WXWuXi Pharmatech (Cay...+0.23+0.62%
THRXTheravance Inc-0.67-2.84%
ACADACADIA Pharmaceutica...+2.63+10.97%
MNKDMannkind Corp-0.15-2.04%
Data as of 4:03pm ET, 09/02/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts